Abstract
As combinations and sequences of anthracyclines and taxanes increasingly become standard adjuvant treatment for early breast cancer, a major need for new treatment options for metastatic breast cancer will arise. Vinorelbine is highly active in the treatment of metastatic breast cancer, both as a single agent and in combination regimens. Furthermore, it is well tolerated, with a low incidence of subjective toxicities. It is anticipated, therefore, that vinorelbine will become increasingly utilized for treating metastatic breast cancer due to its favorable safety profile, good tolerability, and promising results in combination with other chemotherapy agents. Combinations with trastuzumab and newer molecular targeting agents are being explored. Doublets or triplets of vinorelbine with drugs other than anthracyclines and taxanes could be considered in the next generation of adjuvant and neoadjuvant trials, where it is anticipated that anthracycline/taxane combinations are likely to replace anthracycline/cyclophosphamide combinations as the mainstay of adjuvant treatment.
References
Aug 15, 1990·International Journal of Cancer. Journal International Du Cancer·S BinetV Meininger
Jan 1, 1983·Cancer Chemotherapy and Pharmacology·K Kolarić, A Roth
Oct 1, 1995·American Journal of Clinical Oncology·S BrunoG Kesselring
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T Le ChevalierS Cigolari
Sep 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J GehlP Dombernowsky
Aug 8, 1998·Breast Cancer Research and Treatment·E BaldiniP Conte
Sep 10, 1998·Oncology·A Llombart-CussacM Spielmann
Mar 26, 1999·Cancer·C BlajmanF M Delgado
May 18, 1999·Oncogene·M PegramD Slamon
Jun 11, 1999·American Journal of Clinical Oncology·A I ShamseddineN S El Saghir
Oct 3, 1999·Cancer·N K IbrahimG N Hortobagyi
Oct 6, 1999·Biochemical Pharmacology·P Verdier-PinardM Wright
Oct 12, 1999·Breast Cancer Research and Treatment·K HaiderW Scheithauer
Oct 12, 1999·Breast Cancer Research and Treatment·Y KanoS Tsunoda
Dec 22, 1999·Cancer Chemotherapy and Pharmacology·F LoboL G Estévez
Jan 25, 2000·Oncology·P ViciM Lopez
Jan 25, 2000·Oncology·S De PlacidoA R Bianco
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D I UdomR C Coombes
Jun 1, 2000·Breast Cancer Research and Treatment·C NisticòE Terzoli
May 30, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M NamerJ L Wendling
Citations
Sep 26, 2012·Onkologie·Cordula SchippertHans-Joachim Lück
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Filippo MontemurroMassimo Aglietta
Aug 10, 2010·Cancer Investigation·Denise A YardleyJohn D Hainsworth
Nov 22, 2002·Cancer Investigation·Catherine Van Poznak, Andrew D Seidman
Feb 20, 2010·La Revue de médecine interne·C Lebrun, M Frenay
Oct 8, 2009·Clinical Therapeutics·Alvaro Moreno-Aspitia, Edith A Perez
Jul 25, 2008·Clinical Breast Cancer·Juan Lucas Bayo-CaleroAlfonso Yubero-Esteban
Jan 17, 2013·The Breast Journal·Ying-Chun XuFeng-Chun Zhang
Feb 19, 2005·Seminars in Oncology·Nicholas J RobertAlberto A Gabizon
Apr 22, 2015·Leukemia Research·Sandra KellerThomas Pabst
Feb 5, 2005·Onkologie·Hans-Joachim StemmlerVolker Heinemann
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinEric P Winer
Feb 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven A LimentaniDeborah Lewis
Jun 16, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CocconiUNKNOWN Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy
Sep 16, 2005·Cancer Chemotherapy and Pharmacology·Rogier R PressOlaf van Tellingen
Jan 1, 2010·Aesthetic Plastic Surgery·Yalcin BayramNurettin Noyan
Jun 16, 2010·Environmental Toxicology·Dimitris Vlastos, Alexandros Ntinopoulos
Jul 7, 2012·Molecular Pharmacology·Jurjen S LagasAlfred H Schinkel
Jul 3, 2020·Cancer Biotherapy & Radiopharmaceuticals·Haochen WangYinghua Zou